The European Patent Office revokes an Edwards Lifesciences transcatheter aortic valve patent that has been the center of a long-running feud with Medtronic.
A study in the Annals of Internal Medicine finds that transcatheter aortic valve implants improve cardiovascular health but might not do as much for quality of life.
Get the complete picture with a MassDevice Plus membership. Registered users can login here.
Medtronic asks a Delaware federal judge to overturn a $393 million patent infringement loss to Edwards Lifesciences over their respective replacement heart valves.
Edwards Lifesciences receives CE Mark approval in the European Union for its next-generation Sapien XT transcatheter valve implantation system, landing indications for either mitral or aortic valve-in-valve procedures.
Edwards Lifesciences beats Wall Street's forecast for the 4th quarter, but says its replacement mitral valve program was delayed while it waited for FDA approval to begin a 1st-in-human trial.
Edwards Lifesciences' newly CE-Marked Sapien 3 transcatheter heart valve features a lower profile delivery sheath and an outer skirt to help prevent leakage.
A federal appeals court upholds a lower court's decision in favor of Edwards Lifesciences in their ongoing patent infringement war over replacement heart valve technology.
Need Medtech news in a minute? We Deliver!
MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.
News and information for the medical device industry and the companies that drive it. Learn the latest about sales, jobs, legislation and other areas of the medtech industry.